发明名称 PYRAZOLE COMPOUND
摘要 PROBLEM TO BE SOLVED: To provide a pyrazole compound having CB1 (central cannabinoid) receptor antagonizing actions. SOLUTION: The pyrazole compound is a compound represented by general formula [I] [wherein, R<SP>1</SP>and R<SP>2</SP>are each an aryl group or the like which may have a substituent; R<SP>3</SP>is an alkyl group or the like which may be substituted with a halogen atom or the like; E is a group represented by any of formulas (i) to (iv) äwherein, R<SP>4</SP>is a cycloalkyl group, a group represented by formula -N(R<SP>5</SP>)(R<SP>6</SP>) or a saturated or an unsaturated heterocyclic group which may have a substituent; Q<SP>1</SP>is a single direct bond or the like; Q<SP>2</SP>is a single direct bond or the like; either of R<SP>5</SP>and R<SP>6</SP>is a hydrogen atom or the like; and the other is an alkyl group, a group or the like represented by formula -N(R<SP>8</SP>)(R<SP>9</SP>) (wherein, either of R<SP>8</SP>and R<SP>9</SP>is a hydrogen atom or the like and the other is an alkyl group or the like); R<SP>A1</SP>is an amino group or the like; R<SP>A2</SP>is an aliphatic heterocyclic group which may have a substituent; and R represents an alkyl group or the like which may be substituted with 1-3 halogen atoms}] or a pharmacologically acceptable salt thereof. COPYRIGHT: (C)2008,JPO&INPIT
申请公布号 JP2008024693(A) 申请公布日期 2008.02.07
申请号 JP20060285608 申请日期 2006.10.20
申请人 MITSUBISHI TANABE PHARMA CORP 发明人 MORITANI YASUNORI;IMASHIRO RITSUO;SATO ATSUSHI
分类号 C07D231/18;A61K31/415;A61K31/4155;A61K31/4188;A61K31/422;A61K31/4245;A61K31/4439;A61K31/454;A61K31/496;A61K31/497;A61K31/506;A61K31/5377;A61K31/541;A61K31/55;A61P1/04;A61P1/08;A61P1/12;A61P1/16;A61P3/04;A61P3/06;A61P3/10;A61P9/02;A61P9/10;A61P9/12;A61P11/06;A61P13/00;A61P15/00;A61P25/00;A61P25/06;A61P25/08;A61P25/16;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P27/06;A61P35/00;A61P37/02;C07D231/40;C07D401/12;C07D401/14;C07D403/06;C07D403/12;C07D405/12;C07D409/12;C07D413/04;C07D413/12;C07D487/10 主分类号 C07D231/18
代理机构 代理人
主权项
地址